Green Cross Essential Therapeutics LLC entered the industry of Malaria Control in 2004 and has grown to employ 1 to 4 people, generating an annual revenue of $100.000 to $499.999. The NAICS classifies this business under the code 561710, which describes it as a Malaria Control. For further clarification, the SIC classifies this business under the code 4959 and described it as a Malaria Control. The business provides service to the B2B market.
To acquire more information, please contact Myung Hi Sonserai Lee by calling (917) 680-2905 during business hours. You can also write to the business’ Single Location at Uknown, New York City, New York NY 10036. You can also visit the company’s website at . View this business’ social media profiles on Twitter or on Facebbok .
| Company: | Green Cross Essential Therapeutics LLC |
| Representative: | Myung Hi Sonserai Lee |
| Place of Business: | Uknown, New York City, NY 10036 |
| Contact Number: | (917) 680-2905 |
| Type of Service: | Malaria Control |
| SIC Number: | 4959 |
| NAICS Number: | 561710 |
| Locality: | Single Location |
| Market Type: | B2B (Business to Business) |
| Began: | 2004 |
| Income/Year: | $100.000 to $499.999 |
| Laborers: | 1 to 4 |
| Share This Company: |
Green Cross Essential Therapeutics LLC is a company operating from New York, New York providing professional Malaria Control and relevant B2B variables. It was founded in 2004 and registered with the SIC code 4959 as Malaria Control, and with the NAICS code 561710 as Malaria Control.
With a current employee count of 1 to 4, Green Cross Essential Therapeutics LLC has gone to report making $100.000 to $499.999 per annum on its journey towards growth. This company invites you to contact its representative Myung Hi Sonserai Lee at (917) 680-2905 for related queries, or to locate its Single Location using the coordinates .
The Single Location can also be found at the street address Uknown in New York City, New York 10036 and can be engaged online through the company website at , the company Twitter , and Facebook page .